Cargando…
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
During tumor progression, a subset of cancer cells escape from immune surveillance and eventually develop into measurable tumor mass. Cancer immunotherapy eradicates tumor cells by enhancing multiple steps in cancer-immunity cycle including antigen presentation, T cell priming, activation, and immun...
Autores principales: | Li, Anping, Yi, Ming, Qin, Shuang, Song, Yongping, Chu, Qian, Wu, Kongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444510/ https://www.ncbi.nlm.nih.gov/pubmed/30935414 http://dx.doi.org/10.1186/s13045-019-0721-x |
Ejemplares similares
-
cGAS-STING, an important pathway in cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2020) -
Cancer immunotherapy strategies that target the cGAS-STING pathway
por: Tian, Zhuoying, et al.
Publicado: (2022) -
The cGAS-STING Pathway: A Promising Immunotherapy Target
por: Ou, Liang, et al.
Publicado: (2021) -
cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer
por: Dan, Qinfu, et al.
Publicado: (2023) -
cGAS/STING: novel perspectives of the classic pathway
por: Gao, Menghui, et al.
Publicado: (2020)